Social Determinants of Health Research Center, Shahid Beheshti University of Medical Sciences.
  • Register
  • Login

Social Determinants of Health

  • Home
  • Journal Info
    • About the Journal
    • Indexing & Abstracting
    • Privacy Statement
    • Contact
  • Issues
    • Current
    • Archives
  • Submission Instructions
  • Editorial Team
Advanced Search
  1. Home
  2. Archives
  3. Vol. 4 No. 4 (2018)
  4. Case Report

Vol. 4 No. 4 (2018)

January 2019

Back to the Individual-Social Life in patient with Avascular necrosis of femur by Bioresonance Technology (Case Report)

  • Mehrdad Imanzadeh
  • Ahmad Shafaeizadeh
  • Hamid Keshvari
  • Hamidreza Taheri Yegane
  • Mostafa Bahman Abadi
  • Mehran Zeynali Pure

Social Determinants of Health, Vol. 4 No. 4 (2018), 22 January 2019
https://doi.org/10.22037/sdh.v4i4.25569 Published: 2018-12-07

  • View Article
  • Download
  • Cite
  • References
  • Statastics
  • Share

Abstract

Background: More than 20,000 people annually develop avascular necrosis (AVN) worldwide, most of whom aged 20 to 50 years, and should refer to orthopedic surgeons for treatment. The quality of life of such patients is low due to chronic pain and sometimes they are deprived of their occupation and social life.

Case Report: A 57-year-old male patient who developed AVN due to long-term treatment with corticosteroids and their complications was significantly recovered following EPT therapy in a three-year follow-up. Regarding the correlation between chronic diseases and SDH, to treat such patients, improve their quality of life, and help them back normal life, safe complementary therapies, such as bioresonance, are recommended.

 

Keywords:
  • Avascular Necrosis(A.V.N)
  • Chronic Pain
  • Bioresonance
  • SDH
  • PDF

How to Cite

Imanzadeh, M., Shafaeizadeh, A., Keshvari, H. ., Taheri Yegane, H. ., Bahman Abadi, M., & Zeynali Pure, M. . (2018). Back to the Individual-Social Life in patient with Avascular necrosis of femur by Bioresonance Technology (Case Report). Social Determinants of Health, 4(4). https://doi.org/10.22037/sdh.v4i4.25569
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

References

Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy, Asthma & Clinical Immunology. 2013;9(1):30.

Buchman AL. Side effects of corticosteroid therapy. Journal of clinical gastroenterology. 2001;33(4):289-94.

Peretz A, Guillaume M-P, Casper-Velu L. Uveitis management: a multidisciplinary approach to assess systemic involvement and side effects of treatments. Acta Clinica Belgica. 2002;57(3):142-7.

Smith WM, Larson TA, Meleth AD, Krishnadev N, Nussenblatt RB, Sen HN. Corticosteroid-associated osteonecrosis: a rare, but serious, complication in uveitis. Ocular immunology and inflammation. 2013;21(2):102-7.

Nowak DA, Yeung J. Steroid-induced osteonecrosis in dermatology: a review. Journal of cutaneous medicine and surgery. 2015;19(4):358-60.

Moya-Angeler J, Gianakos AL, Villa JC, Ni A, Lane JM. Current concepts on osteonecrosis of the femoral head. World journal of orthopedics. 2015;6(8):590.

Mont MA, Cherian JJ, Sierra RJ, Jones LC, Lieberman JR. Nontraumatic Osteonecrosis of the femoral head: where do we stand today?: a ten-year update. JBJS. 2015;97(19):1604-27.

Ianchiș-Ghețe I. Study of AD bio-phyto-modulators in pain management-arthrosis. Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca Horticulture. 2011;68(2):433-8.

  • Abstract Viewed: 299 times
  • PDF Downloaded: 185 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram

Make a Submission

Make a Submission

Information

  • For Readers
  • For Authors
  • For Librarians
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

 

 

 

Powered by OJSPlus